Eintrag weiter verarbeiten
Preclinical Development of a Neutral, Estrogen Receptor–Targeted, Tridentate99mTc(I)-Estradiol-Pyridin-2-yl Hydrazine Derivative for Imaging of Breast and Endometrial Cancers
Gespeichert in:
| Zeitschriftentitel: | Journal of Nuclear Medicine |
|---|---|
| Personen und Körperschaften: | , , , , , , , |
| In: | Journal of Nuclear Medicine, 49, 2008, 6, S. 978-986 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Society of Nuclear Medicine
|
| Schlagwörter: |
| author_facet |
Nayak, Tapan K. Hathaway, Helen J. Ramesh, Chinnasamy Arterburn, Jeffrey B. Dai, Donghai Sklar, Larry A. Norenberg, Jeffrey P. Prossnitz, Eric R. Nayak, Tapan K. Hathaway, Helen J. Ramesh, Chinnasamy Arterburn, Jeffrey B. Dai, Donghai Sklar, Larry A. Norenberg, Jeffrey P. Prossnitz, Eric R. |
|---|---|
| author |
Nayak, Tapan K. Hathaway, Helen J. Ramesh, Chinnasamy Arterburn, Jeffrey B. Dai, Donghai Sklar, Larry A. Norenberg, Jeffrey P. Prossnitz, Eric R. |
| spellingShingle |
Nayak, Tapan K. Hathaway, Helen J. Ramesh, Chinnasamy Arterburn, Jeffrey B. Dai, Donghai Sklar, Larry A. Norenberg, Jeffrey P. Prossnitz, Eric R. Journal of Nuclear Medicine Preclinical Development of a Neutral, Estrogen Receptor–Targeted, Tridentate99mTc(I)-Estradiol-Pyridin-2-yl Hydrazine Derivative for Imaging of Breast and Endometrial Cancers Radiology, Nuclear Medicine and imaging |
| author_sort |
nayak, tapan k. |
| spelling |
Nayak, Tapan K. Hathaway, Helen J. Ramesh, Chinnasamy Arterburn, Jeffrey B. Dai, Donghai Sklar, Larry A. Norenberg, Jeffrey P. Prossnitz, Eric R. 0161-5505 2159-662X Society of Nuclear Medicine Radiology, Nuclear Medicine and imaging http://dx.doi.org/10.2967/jnumed.107.048546 Preclinical Development of a Neutral, Estrogen Receptor–Targeted, Tridentate<sup>99m</sup>Tc(I)-Estradiol-Pyridin-2-yl Hydrazine Derivative for Imaging of Breast and Endometrial Cancers Journal of Nuclear Medicine |
| doi_str_mv |
10.2967/jnumed.107.048546 |
| facet_avail |
Online Free |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjk2Ny9qbnVtZWQuMTA3LjA0ODU0Ng |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjk2Ny9qbnVtZWQuMTA3LjA0ODU0Ng |
| institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 |
| imprint |
Society of Nuclear Medicine, 2008 |
| imprint_str_mv |
Society of Nuclear Medicine, 2008 |
| issn |
2159-662X 0161-5505 |
| issn_str_mv |
2159-662X 0161-5505 |
| language |
English |
| mega_collection |
Society of Nuclear Medicine (CrossRef) |
| match_str |
nayak2008preclinicaldevelopmentofaneutralestrogenreceptortargetedtridentate99mtciestradiolpyridin2ylhydrazinederivativeforimagingofbreastandendometrialcancers |
| publishDateSort |
2008 |
| publisher |
Society of Nuclear Medicine |
| recordtype |
ai |
| record_format |
ai |
| series |
Journal of Nuclear Medicine |
| source_id |
49 |
| title |
Preclinical Development of a Neutral, Estrogen Receptor–Targeted, Tridentate99mTc(I)-Estradiol-Pyridin-2-yl Hydrazine Derivative for Imaging of Breast and Endometrial Cancers |
| title_unstemmed |
Preclinical Development of a Neutral, Estrogen Receptor–Targeted, Tridentate99mTc(I)-Estradiol-Pyridin-2-yl Hydrazine Derivative for Imaging of Breast and Endometrial Cancers |
| title_full |
Preclinical Development of a Neutral, Estrogen Receptor–Targeted, Tridentate99mTc(I)-Estradiol-Pyridin-2-yl Hydrazine Derivative for Imaging of Breast and Endometrial Cancers |
| title_fullStr |
Preclinical Development of a Neutral, Estrogen Receptor–Targeted, Tridentate99mTc(I)-Estradiol-Pyridin-2-yl Hydrazine Derivative for Imaging of Breast and Endometrial Cancers |
| title_full_unstemmed |
Preclinical Development of a Neutral, Estrogen Receptor–Targeted, Tridentate99mTc(I)-Estradiol-Pyridin-2-yl Hydrazine Derivative for Imaging of Breast and Endometrial Cancers |
| title_short |
Preclinical Development of a Neutral, Estrogen Receptor–Targeted, Tridentate99mTc(I)-Estradiol-Pyridin-2-yl Hydrazine Derivative for Imaging of Breast and Endometrial Cancers |
| title_sort |
preclinical development of a neutral, estrogen receptor–targeted, tridentate<sup>99m</sup>tc(i)-estradiol-pyridin-2-yl hydrazine derivative for imaging of breast and endometrial cancers |
| topic |
Radiology, Nuclear Medicine and imaging |
| url |
http://dx.doi.org/10.2967/jnumed.107.048546 |
| publishDate |
2008 |
| physical |
978-986 |
| description |
|
| container_issue |
6 |
| container_start_page |
978 |
| container_title |
Journal of Nuclear Medicine |
| container_volume |
49 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792347071249907712 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T17:49:26.843Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Preclinical+Development+of+a+Neutral%2C+Estrogen+Receptor%E2%80%93Targeted%2C+Tridentate99mTc%28I%29-Estradiol-Pyridin-2-yl+Hydrazine+Derivative+for+Imaging+of+Breast+and+Endometrial+Cancers&rft.date=2008-06-01&genre=article&issn=2159-662X&volume=49&issue=6&spage=978&epage=986&pages=978-986&jtitle=Journal+of+Nuclear+Medicine&atitle=Preclinical+Development+of+a+Neutral%2C+Estrogen+Receptor%E2%80%93Targeted%2C+Tridentate%3Csup%3E99m%3C%2Fsup%3ETc%28I%29-Estradiol-Pyridin-2-yl+Hydrazine+Derivative+for+Imaging+of+Breast+and+Endometrial+Cancers&aulast=Prossnitz&aufirst=Eric+R.&rft_id=info%3Adoi%2F10.2967%2Fjnumed.107.048546&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792347071249907712 |
| author | Nayak, Tapan K., Hathaway, Helen J., Ramesh, Chinnasamy, Arterburn, Jeffrey B., Dai, Donghai, Sklar, Larry A., Norenberg, Jeffrey P., Prossnitz, Eric R. |
| author_facet | Nayak, Tapan K., Hathaway, Helen J., Ramesh, Chinnasamy, Arterburn, Jeffrey B., Dai, Donghai, Sklar, Larry A., Norenberg, Jeffrey P., Prossnitz, Eric R., Nayak, Tapan K., Hathaway, Helen J., Ramesh, Chinnasamy, Arterburn, Jeffrey B., Dai, Donghai, Sklar, Larry A., Norenberg, Jeffrey P., Prossnitz, Eric R. |
| author_sort | nayak, tapan k. |
| container_issue | 6 |
| container_start_page | 978 |
| container_title | Journal of Nuclear Medicine |
| container_volume | 49 |
| description | |
| doi_str_mv | 10.2967/jnumed.107.048546 |
| facet_avail | Online, Free |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMjk2Ny9qbnVtZWQuMTA3LjA0ODU0Ng |
| imprint | Society of Nuclear Medicine, 2008 |
| imprint_str_mv | Society of Nuclear Medicine, 2008 |
| institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161 |
| issn | 2159-662X, 0161-5505 |
| issn_str_mv | 2159-662X, 0161-5505 |
| language | English |
| last_indexed | 2024-03-01T17:49:26.843Z |
| match_str | nayak2008preclinicaldevelopmentofaneutralestrogenreceptortargetedtridentate99mtciestradiolpyridin2ylhydrazinederivativeforimagingofbreastandendometrialcancers |
| mega_collection | Society of Nuclear Medicine (CrossRef) |
| physical | 978-986 |
| publishDate | 2008 |
| publishDateSort | 2008 |
| publisher | Society of Nuclear Medicine |
| record_format | ai |
| recordtype | ai |
| series | Journal of Nuclear Medicine |
| source_id | 49 |
| spelling | Nayak, Tapan K. Hathaway, Helen J. Ramesh, Chinnasamy Arterburn, Jeffrey B. Dai, Donghai Sklar, Larry A. Norenberg, Jeffrey P. Prossnitz, Eric R. 0161-5505 2159-662X Society of Nuclear Medicine Radiology, Nuclear Medicine and imaging http://dx.doi.org/10.2967/jnumed.107.048546 Preclinical Development of a Neutral, Estrogen Receptor–Targeted, Tridentate<sup>99m</sup>Tc(I)-Estradiol-Pyridin-2-yl Hydrazine Derivative for Imaging of Breast and Endometrial Cancers Journal of Nuclear Medicine |
| spellingShingle | Nayak, Tapan K., Hathaway, Helen J., Ramesh, Chinnasamy, Arterburn, Jeffrey B., Dai, Donghai, Sklar, Larry A., Norenberg, Jeffrey P., Prossnitz, Eric R., Journal of Nuclear Medicine, Preclinical Development of a Neutral, Estrogen Receptor–Targeted, Tridentate99mTc(I)-Estradiol-Pyridin-2-yl Hydrazine Derivative for Imaging of Breast and Endometrial Cancers, Radiology, Nuclear Medicine and imaging |
| title | Preclinical Development of a Neutral, Estrogen Receptor–Targeted, Tridentate99mTc(I)-Estradiol-Pyridin-2-yl Hydrazine Derivative for Imaging of Breast and Endometrial Cancers |
| title_full | Preclinical Development of a Neutral, Estrogen Receptor–Targeted, Tridentate99mTc(I)-Estradiol-Pyridin-2-yl Hydrazine Derivative for Imaging of Breast and Endometrial Cancers |
| title_fullStr | Preclinical Development of a Neutral, Estrogen Receptor–Targeted, Tridentate99mTc(I)-Estradiol-Pyridin-2-yl Hydrazine Derivative for Imaging of Breast and Endometrial Cancers |
| title_full_unstemmed | Preclinical Development of a Neutral, Estrogen Receptor–Targeted, Tridentate99mTc(I)-Estradiol-Pyridin-2-yl Hydrazine Derivative for Imaging of Breast and Endometrial Cancers |
| title_short | Preclinical Development of a Neutral, Estrogen Receptor–Targeted, Tridentate99mTc(I)-Estradiol-Pyridin-2-yl Hydrazine Derivative for Imaging of Breast and Endometrial Cancers |
| title_sort | preclinical development of a neutral, estrogen receptor–targeted, tridentate<sup>99m</sup>tc(i)-estradiol-pyridin-2-yl hydrazine derivative for imaging of breast and endometrial cancers |
| title_unstemmed | Preclinical Development of a Neutral, Estrogen Receptor–Targeted, Tridentate99mTc(I)-Estradiol-Pyridin-2-yl Hydrazine Derivative for Imaging of Breast and Endometrial Cancers |
| topic | Radiology, Nuclear Medicine and imaging |
| url | http://dx.doi.org/10.2967/jnumed.107.048546 |